Elevance Health Files 8-K for Regulation FD Disclosure
Ticker: ELV · Form: 8-K · Filed: Sep 4, 2025 · CIK: 1156039
Sentiment: neutral
Topics: disclosure, regulation-fd
Related Tickers: ELV
TL;DR
Elevance Health (formerly Anthem) filed a standard 8-K for a Reg FD disclosure on Sept 4, 2025. No new material info revealed.
AI Summary
Elevance Health, Inc. filed an 8-K on September 4, 2025, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or new material events beyond the disclosure itself. The company, formerly known as Anthem, Inc., is incorporated in Indiana and headquartered in Indianapolis.
Why It Matters
This filing indicates Elevance Health is making a public disclosure under Regulation FD, ensuring all investors receive the same material information simultaneously. It does not, however, reveal any new financial performance or strategic changes.
Risk Assessment
Risk Level: low — The filing is a routine disclosure under Regulation FD and does not contain any new material information that would typically impact stock price or indicate significant risk.
Key Players & Entities
- Elevance Health, Inc. (company) — Registrant
- Anthem, Inc. (company) — Former company name
- September 4, 2025 (date) — Date of report
- Indiana (location) — State of incorporation
- Indianapolis (location) — Principal executive offices city
FAQ
What is the primary purpose of this 8-K filing by Elevance Health?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure, ensuring that any material non-public information is simultaneously disclosed to the public.
When was this 8-K filed by Elevance Health?
This 8-K was filed on September 4, 2025.
What was Elevance Health's former name?
Elevance Health, Inc. was formerly known as Anthem, Inc.
In which state was Elevance Health incorporated?
Elevance Health, Inc. was incorporated in Indiana.
Does this filing contain specific financial results or new material events?
No, this filing is specifically for a Regulation FD Disclosure and does not appear to contain specific financial results or details of new material events beyond the act of disclosure itself.
Filing Stats: 1,300 words · 5 min read · ~4 pages · Grade level 16.7 · Accepted 2025-09-04 06:02:07
Key Financial Figures
- $0.01 — ch registered Common Stock, Par Value $0.01 ELV NYSE Indicate by check mark whe
- $24.10 — for full year 2025 to be approximately $24.10 per diluted share, including approximat
- $5.90 — diluted share, including approximately $5.90 per diluted share of net unfavorable it
- $30.00 — reholders' earnings to be approximately $30.00 per diluted share. This does not includ
Filing Documents
- elv-20250904.htm (8-K) — 30KB
- 0001156039-25-000129.txt ( ) — 172KB
- elv-20250904.xsd (EX-101.SCH) — 2KB
- elv-20250904_def.xml (EX-101.DEF) — 14KB
- elv-20250904_lab.xml (EX-101.LAB) — 24KB
- elv-20250904_pre.xml (EX-101.PRE) — 15KB
- elv-20250904_htm.xml (XML) — 3KB
FORWARD-LOOKING STATEMENTS
FORWARD-LOOKING STATEMENTS This document contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our views about future events and financial performance and are generally not historical facts. Words such as "expect," "feel," "believe," "will," "may," "should," "anticipate," "intend," "estimate," "project," "forecast," "plan" and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to: financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. You are also urged to carefully review and consider the various risks and other disclosures discussed in our reports filed with the U.S. Securities and Exchange Commission from time to time, which attempt to advise interested parties of the factors that affect our business. Except to the extent required by law, we do not update or revise any forward-looking statements to reflect events or circumstances occurring after the date hereof. These risks and uncertainties include, but are not limited to: trends in healthcare costs and utilization rates; reduced enrollment; our ability to secure and implement sufficient premium rates; the impact of large scale medical emergencies, such as public health epidemics and pandemics, and other catastrophes; the impact of new or changes in existing federal, state and internat